Mucocort AB has been granted a patent in Australia for its medical technology innovation. The company has successfully developed M045A, an innovative mucoadhesive "patch" for the treatment of oral aphthous ulcers.
Lina Olsson, former CEO of HiloProbe, has been appointed Business Unit Manager at Prevas in Umeå, where she will build up the local operations in MedTech and Life Science. The technology consultant firm Prevas aims to build a strong local team and tailor services to community needs.
Tobias Tovedal, a UBI business coach, becomes CEO of Patient Safety Surveillance Solutions (P3S), a KI startup developing software for monitoring healthcare-associated injuries. His leadership aims to enhance patient safety through real-time data analysis and expansion to more hospitals in Sweden.
Umeå Biotech Incubator has been awarded SEK 14.6 million in excellence funding by Vinnova, reaffirming its status as an excellent incubator. This funding, designated for 2025-2029, supports startups' growth, emphasizing sustainability and gender equality in business development.
HILICON, based in Umeå, has achieved record turnover and significant market presence in chromatography within ten years. CEO Wen Jiang aims to launch new products in 2025, expand the premises, and in the long term double the turnover while maintaining a focus on innovation and tailored customer solutions.
MetaCurUm AB has received a SEK 1 million grant from the Swedish Innovation Agency Vinnova to advance its therapeutic antibody for prostate cancer toward clinical trials. The Vinnova funds will be used further to validate MetaCurUm's mechanism of action and product. MetaCurUm is collaborating with the Institute of Cancer Research in London and Professor Johan de Bono.
Four pilot projects will receive dedicated support to accelerate the commercialization of their specific biological product through BRIDGE Sweden. The projects, three Academic and one start-up, will set the standard, help to identify essential offerings and refine the approach at SciLife Lab’s DDD platform, Testa Center and Lund’s Stem Cell Center and pre-GMP facility.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden